These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32064771)

  • 21. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma.
    Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B
    Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bioinformatics analysis for diagnostic roles of the
    Li J; Wang H; Cao F; Cheng Y
    J Gastrointest Oncol; 2022 Oct; 13(5):2115-2131. PubMed ID: 36388667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F family play important roles in tumorigenesis.
    Li FF; Wang Y; Gu JH; Zhang YM; Liu FS; Ni ZH
    Yi Chuan; 2023 Jul; 45(7):580-592. PubMed ID: 37503582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic study on expression and prognosis of E2Fs in human colorectal cancer.
    Ma Y; Wang S; Bao J; Wang C
    Int J Clin Oncol; 2022 Feb; 27(2):362-372. PubMed ID: 34661779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression.
    Yang R; Wang M; Zhang G; Bao Y; Wu Y; Li X; Yang W; Cui H
    Br J Cancer; 2020 Oct; 123(9):1445-1455. PubMed ID: 32814835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma.
    Luo H; Tao C; Long X; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):7765-7779. PubMed ID: 34617871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics Identification of the Expression and Clinical Significance of E2F Family in Endometrial Cancer.
    Zhang Y; Wang Z; Ma J; Huo J; Li Y; Wang Y; Chen H; Shan L; Ma X
    Front Genet; 2020; 11():557188. PubMed ID: 33329696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-damage response control of E2F7 and E2F8.
    Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
    EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F8 as a Novel Therapeutic Target for Lung Cancer.
    Park SA; Platt J; Lee JW; López-Giráldez F; Herbst RS; Koo JS
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of E2F transcription factor in oral cancer: Recent insight and advancements.
    Kassab A; Gupta I; Moustafa AA
    Semin Cancer Biol; 2023 Jul; 92():28-41. PubMed ID: 36924812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma.
    Liu ZG; Su J; Liu H; Yang XJ; Yang X; Wei Y; Zhu XY; Song Y; Zhao XC; Guo HL
    Oncol Lett; 2022 Oct; 24(4):351. PubMed ID: 36168311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
    Yang C; Zhang ZC; Liu TB; Xu Y; Xia BR; Lou G
    Cancer Cell Int; 2020; 20():500. PubMed ID: 33061852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1.
    Weijts BG; Bakker WJ; Cornelissen PW; Liang KH; Schaftenaar FH; Westendorp B; de Wolf CA; Paciejewska M; Scheele CL; Kent L; Leone G; Schulte-Merker S; de Bruin A
    EMBO J; 2012 Oct; 31(19):3871-84. PubMed ID: 22903062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F7 and E2F8 keep the E2F family in balance.
    Moon NS; Dyson N
    Dev Cell; 2008 Jan; 14(1):1-3. PubMed ID: 18194644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma.
    Lin S; Yu X; Yan H; Xu Y; Ma K; Wang X; Liu Y; Xie A; Yu Z
    Medicine (Baltimore); 2024 Jan; 103(3):e34342. PubMed ID: 38241554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.